Next generation ReSTOR

Article

Alcon has launched the +3.0 Add Power AcrySof ReSTOR aspheric intraocular lens (IOL) with natural chromophore. The lens gained its CE mark in late 2007 and has been available throughout the EU since mid-September 2008.

Alcon has launched the +3.0 Add Power AcrySof ReSTOR aspheric intraocular lens (IOL) with natural chromophore. The lens gained its CE mark in late 2007 and has been available throughout the EU since mid-September 2008.

The +3.0 Add Power IOL, a refinement of the +4.0 Add Power lens model, can be inserted through a 2.2 mm incision, and is implanted in exactly the same manner as the +4.0 add lens, eradicating the learning curve.

The lens has been associated with a similar incidence and degree of adverse events as the earlier model, and has a high rate of patient satisfaction. The rate of success is also high: at three months, 94.9% of patients had best corrected visual acuities (near, intermediate and distance combined) of ≥20/40.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.